• Home
  • Subscribe
  • About Our Show
  • Privacy & Compliance
  • Quest Drug Monitoring
  • Guests
      Jack KainJason SuomalaJeff GudinJustin NilesLes EdinboroPat AlagiaRaymond Lorenz

Topics in Drug Testing from Quest Diagnostics

Pat Alagia

Episodes

Special Episode: Trends in drug testing resulting from the COVID-19 pandemic

Friday Aug 27, 2021

Special Episode: Trends in drug testing resulting from the COVID-19 pandemic

Friday Aug 27, 2021

The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic. In this session, Dr Gudin discusses with Dr Pat Alagia on the Quest Dialogues podcast: Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations  Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuse System-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations

Read more

Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2000-2021 Quest Diagnostics Incorporated. All rights reserved.

Podcast Powered By Podbean